Successful Use of Intravenous Immunoglobulin G to Treat Refractory Heparin-Induced Thrombocytopenia With Thrombosis Complicating Peripheral Blood Stem Cell Harvest

• Hoofdauteurs: Devon S. McKenzie MD (Auteur), Josephine Anuforo MD (Auteur), Jennah Morgan MD (Auteur), Elvira Neculiseanu MD (Auteur)
• Formaat: Boek
• Gepubliceerd in: SAGE Publishing, 2018-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Heparin-induced thrombocytopenia is a well-known, life-threatening complication that occurs in 5% of patients exposed to heparin. It causes thrombocytopenia in roughly 85% to 90% of affected individuals, with expected recovery in approximately 4 to 10 days following heparin withdrawal. However, ther...